Oral cladribine and fingolimod for relapsing multiple sclerosis.
Li
Haifeng
H
Zhang
Xu
X
D000284:Administration, Oral; D017338:Cladribine / Q000627:therapeutic use*; D004185:Disability Evaluation; D018450:Disease Progression; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*
D007166:Immunosuppressive Agents; D017338:Cladribine